Published in Cancer on May 15, 1983
Chronic pruritus: a paraneoplastic sign. Dermatol Ther (2010) 1.50
New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol (2010) 0.95
Pruritus in Systemic Diseases: A Review of Etiological Factors and New Treatment Modalities. ScientificWorldJournal (2015) 0.77
Analysis of prognostic factors in lymphoma patients with bone marrow involvement: a single center cohort study. Int J Clin Exp Med (2015) 0.75
Rash that itches and is all over: look beyond the skin. J Community Hosp Intern Med Perspect (2016) 0.75
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J (1995) 3.48
Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol (1993) 2.20
A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol (1988) 1.58
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood (1992) 1.49
Interaction between infrared radiation and vitreous substitutes. Arch Ophthalmol (1997) 1.42
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. Haematologica (1999) 1.38
Quantitative evaluation of erythropoietic activity in dysmyelopoietic syndromes. Br J Haematol (1982) 1.27
Changing clinical presentation of multiple myeloma. Eur J Cancer (1991) 1.24
The ultrastructural localization of factor VIII-antigen in human platelets, megakaryocytes and endothelial cells utilizing a ferritin-labelled antibody. Br J Haematol (1978) 1.21
Inter- and intrasubject variabilities in the pharmacokinetics of rufloxacin after single oral administration to healthy volunteers. Antimicrob Agents Chemother (1991) 1.20
Natural history of idiopathic refractory sideroblastic anemia. Blood (1988) 1.17
Serum albumin in Hodgkin's disease. Cancer (1985) 1.17
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma. Br J Cancer (2000) 1.09
The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas. Haematologica (2000) 1.08
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis. Proc Natl Acad Sci U S A (1995) 1.08
The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature. Cancer (1990) 1.07
Primary splenic lymphoma: does it exist? Haematologica (1994) 1.00
Biologic and clinical significance of red cell ferritin. Blood (1983) 1.00
Immunofluorescent detection of factor VIII-related antigen in human platelets and megakaryoctes. Haemostasis (1974) 1.00
Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity. Br J Haematol (1990) 0.95
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. Br J Haematol (2001) 0.95
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. Hematol Oncol (1990) 0.95
Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet (1983) 0.94
Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias. Br J Haematol (1983) 0.93
Hodgkin's disease prognosis: a directly predictive equation. Lancet (1988) 0.93
Potassium transport and control of glycolysis in human erythrocytes. Am J Physiol (1966) 0.93
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res (1988) 0.93
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. Ann Oncol (2004) 0.93
Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors. Am J Respir Crit Care Med (1997) 0.92
Sheehan's syndrome with complete bone marrow aplasia: long-term results of substitution therapy with hormones. Br J Haematol (1976) 0.92
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants. Br J Haematol (1989) 0.91
A prognostic index for multiple myeloma. Br J Cancer (1996) 0.90
Control of glycolysis in human erythrocytes by inorganic phosphate and sulfate. Am J Physiol (1966) 0.89
The degrees of plasma cell clonality and marrow infiltration adversely influence the prognosis of AL amyloidosis patients. Haematologica (1999) 0.89
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. Haematologica (1975) 0.89
Epsilon-aminocaproic acid for synovectomy in haemophilic patients. Acta Haematol (1972) 0.88
Proliferative activity of bone marrow cells in primary dysmyelopoietic (preleukemic) syndromes. Cancer (1983) 0.88
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. Leukemia (1993) 0.87
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. Haematologica (1997) 0.87
Anti-phospholipid antibodies and thrombotic thrombocytopenic purpura. Clin Exp Rheumatol (1988) 0.87
Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in a hematological/oncological outpatient section. Haematologica (1989) 0.87
Isolation of Reed-Sternberg cells from lymph nodes of Hodgkin's disease patients. Blood (1989) 0.86
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. Cancer (1991) 0.86
Improvement of hyperinsulinemic diabetes following removal of a meningioma in Werner's syndrome. A case report. Acta Diabetol Lat (1984) 0.85
Biological features of the clone involved in primary amyloidosis (AL). Leukemia (2001) 0.84
Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia. Blut (1989) 0.84
New clinical criteria for the assessment of liver involvement in Hodgkin's disease. Eur J Cancer Clin Oncol (1982) 0.84
Silymarine during maintenance therapy of acute promyelocytic leukemia. Haematologica (1994) 0.84
Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL). Haematologica (1999) 0.84
Type IV Ehlers Danlos syndrome and factor IX deficiency: a case report. Haematologica (1986) 0.84
The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma refractory to chemotherapy. Int J Clin Lab Res (1998) 0.84
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP. Haematologica (1995) 0.84
Acute rhabdomyolysis after high dose chemotherapy and circulating progenitor cell autografting for breast cancer. Haematologica (2000) 0.83
ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial. Ann Oncol (2002) 0.83
Studies of ineffective erythropoiesis and peripheral haemolysis in congenital dyserythropoietic anaemia type II. Br J Haematol (1979) 0.83
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL. Haematologica (1998) 0.83
IgA nephropathy and Henoch-Schonlein syndrome occurring in the same patient. Nephron (1996) 0.83
Surgical and chemical synovectomy. Ann N Y Acad Sci (1975) 0.82
Treatment of AL amyloidosis with 4'-lodo-4'-deoxydoxorubicin: an update. Blood (1999) 0.82
Serum cytokine levels after small bowel transplantation in pigs. Transplant Proc (1994) 0.82
Marked eosinophilia associated with acute lymphoblastic leukemia. Haematologica (1976) 0.82
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol. Eur J Cancer (2003) 0.82
Photorefractive keratectomy for hyperopia using an erodible disc and axicon lens: 2-year results. J Refract Surg (1998) 0.82
Membrane glycopeptides from old and young human erythrocytes. Biochem J (1974) 0.82
Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma. J Clin Pathol (1990) 0.82
Immunological reactivity of serum ferritin in patients with malignancy. Tumori (1985) 0.82
Expression of p53, bcl-2 and ras oncoproteins and apoptosis levels in acute leukaemias and myelodysplastic syndromes. Leuk Lymphoma (2001) 0.81
Serum thymidine kinase and beta-2 microglobulin in monoclonal gammopathies. Tumori (1987) 0.81
Plasma cell DNA content in multiple myeloma and related paraproteinemic disorders. Relationship with clinical and cytokinetic features. Eur J Cancer Clin Oncol (1984) 0.81
Rate of M-component changes and plasma cell labeling index in 25 patients with multiple myeloma treated with peptichemio. Cancer Treat Rep (1985) 0.81
Cell cycle-related proteins: a flow cytofluorometric study in human tumors. Biol Cell (1988) 0.81
Image-aided estimate of tumor burden in Hodgkin's disease: evidence of its primary prognostic importance. J Clin Oncol (2001) 0.81
Purpura fulminans as clinical manifestation of atypical SLE with antiphospholipid antibodies: a case report. Haematologica (1992) 0.81
Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate. Arch Intern Med (1987) 0.81
The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological study of a case. Haematologica (1991) 0.81
Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus. Ther Drug Monit (1987) 0.81
Depletion of stromal and intraepithelial antigen-presenting cells in cervical neoplasia in human immunodeficiency virus infection. Hum Pathol (1996) 0.80
Ploidy and proliferative activity of human brain tumors. A flow cytofluorometric study. Oncology (1987) 0.80
Peptichemio induction therapy in myelomatosis. Cancer Chemother Pharmacol (1982) 0.80
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. Acta Haematol (1981) 0.80
Hodgkin's disease and pregnancy. Haematologica (1984) 0.80
Prognostic factors in non-Hodgkin's lymphomas. Acta Haematol (1985) 0.79
Estimate of expected survival at diagnosis in Hodgkin's disease: a means of weighting prognostic factors and a tool for treatment choice and clinical research. A report from the International Database on Hodgkin's Disease (IDHD). Haematologica (1994) 0.79
Cigarette-smoking effect on platelet function. Thromb Haemost (1977) 0.79
Gene expression of pyrogenic cytokines in Hodgkin's disease lymph nodes. Haematologica (1992) 0.79